Ziconotide combination intrathecal therapy for noncancer pain is limited secondary to delayed adverse effects: A case series with a 24-month follow-up

Salim M. Hayek, Michael C. Hanes, Connie Wang, I. Elias Veizi

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Ziconotide combination intrathecal therapy for noncancer pain is limited secondary to delayed adverse effects: A case series with a 24-month follow-up'. Together they form a unique fingerprint.

Medicine & Life Sciences